Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
175
NCT00002659
Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 1995
Completion: Not specified
NCT00003044
Chemotherapy in Treating Patients With Liver Cancer
Phase: Phase 2
Start: Sep 30, 1996
NCT00022217
Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
Start: Nov 30, 2000